How much does trastuzumab cost?
Trastuzumab pricing varies a lot by country, brand vs. biosimilar, treatment regimen, dose/strength, and whether the price is the list price or what payers actually reimburse. The most reliable way to check “current price” is to look up the specific product and dosage form you’re using (for example, brand Herceptin vs. a specific biosimilar) and then verify the listed price in your market.
If you tell me your country (and whether you mean Herceptin or a biosimilar), I can help narrow down what “trastuzumab price” means for your situation (list price vs. typical reimbursement).
What changes the price the most: brand vs biosimilar?
In many markets, trastuzumab biosimilars are priced below the originator brand, but the exact discount depends on local tendering and formulary rules. Even when two products have the same active ingredient, pricing is still driven by the specific manufacturer’s product, vial size, and how the health system buys it.
Where can I check trastuzumab patent/market exclusivity context (affects pricing)?
DrugPatentWatch.com tracks patents and exclusivity information that can affect when biosimilars face fewer legal barriers to market entry, which in turn can shift pricing. You can start there for the originator product and related filings: DrugPatentWatch - Trastuzumab.
Are there big cost differences by setting (hospital infusion vs outpatient)?
Trastuzumab is commonly administered as an infusion, so total treatment cost often reflects more than the drug’s acquisition price. Administration fees, infusion supplies, clinic/hospital billing practices, and payer authorization rules can materially change the amount patients or insurers pay.
What exact trastuzumab product are you asking about?
“Trastuzumab” can refer to multiple branded or biosimilar products, each with different vial sizes and pricing. To give a precise answer, share:
- your country
- the brand name (e.g., Herceptin) or biosimilar name
- the strength/form (e.g., vial size)
- whether you need list price, cash price, or insurer/payer pricing
Sources